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PURPOSE. The current and projected shortage of transplantable human donor corneas has
prompted the development of long-term alternatives to human donor tissue for corneal
replacement. The biosynthetic stromal substitutes (BSS) characterized herein represent a
potentially safe alternative to donor organ transplantation for anterior corneal stromal
diseases. The goal of this phase 1 safety study was to characterize the three-dimensional (3D)
corneal shape of the first 10 human patients implanted with a BSS and assess its stability over
time.
METHODS. Ten patients underwent anterior lamellar keratoplasty using a biosynthetic corneal
stromal implant for either advanced keratoconus or central corneal scarring. Surgeries were
performed at Linko¨ping University Hospital, between October and November 2007. Serial
corneal topographies were performed on all eyes up to a 4-year follow-up when possible.
Three-dimensional shape average maps were constructed for the 10 BSS corneas and for 10
healthy controls. Average 3D shape corneal elevation maps, difference maps, and statistics
maps were generated.
RESULTS. The biosynthetic stromal substitutes implants remained stably integrated into the
host corneas over the 4-year follow-up period, without signs of wound dehiscence or implant
extrusion. The biosynthetic stromal substitutes corneas showed steeper surface curvatures
and were more irregular than the healthy controls.
CONCLUSIONS. Corneal astigmatism and surface steepness were observed 4 years after BSS
implantation, while the implants remained stably integrated in the host corneas. Future
studies will indicate if biomaterials technology will allow for the optimization of
postoperative surface irregularity after anterior stromal replacement, a new window of
opportunity that is not available with traditional corneal transplantation techniques.
Keywords: corneal implants, artificial cornea, corneal topography, corneal transplantation,
keratoconus
Corneal blindness is the fourth leading cause of blindnessworldwide. Despite the 100,000 transplantations per-
formed every year, making the cornea one of the most
commonly transplanted tissues,1 prevalence of corneal blind-
ness continues to rise, with around 2 million new cases per
year.2 Eye banks are unable to meet this demand and as a result,
approximately 10 million patients are currently awaiting
corneal transplantation.3
The rapidly evolving lamellar keratoplasty techniques seen
of late has permitted to alleviate the exclusion criteria for tissue
donation and increase the proportion of transplantable donor
corneas, thus decreasing the waiting list for corneal transplan-
tation. For instance, in Descemet’s membrane endothelial
keratoplasty (DMEK), only the endothelial and Descemet’s
membrane (DM) layers are transplanted, allowing eye banks to
accept epithelial damage or stromal scars. Similarly, in deep
anterior lamellar keratoplasty (DALK), only the corneal layers
anterior to DM are transplanted. Descemet’s membrane
endothelial keratoplasty and DALK thus allow the safe use of
donor corneas that would be rejected for penetrating kerato-
plasty (PK). Some surgeons have begun performing split-cornea
transplantation, using the anterior (epithelium, Bowman layer,
and stroma) and posterior (endothelium-Descemet membrane
layer) portions for two different patients in the hope of
reducing the need for donor tissue by 50%.4 This practice
remains uncommon. Keratoprostheses (KPros) also salvage a
small portion of corneas otherwise deemed unusable, given
that in these cases, the donor cornea only serves as structural
support for the prosthesis. These surgical techniques, by
themselves, however, will not resolve the current and projected
issue of worldwide shortage of transplantable human donor
corneas, and there remains an unmet need for long-term
alternatives to human donor tissue.
The new concept of biosynthetic corneal substitute
technology, whether partial or full thickness, represents a
major breakthrough in the realm of corneal replacement. The
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ideal corneal substitute would allow safe replacement of the
diseased corneal layers, without risk of disease transmission
from the donor or risk of immune rejection, and would allow
for full rehabilitation of the corneal optical, biomechanical, and
protective functions. It would also be affordable and commer-
cially available in large numbers.
In 2010, Fagerholm et al.5 published the first follow-up
results of a phase I safety study where biosynthetic
analogues of human corneal stromal matrices, comprising
carbodiimide cross-linked recombinant human collagen
(RHCIII, FibroGen, Inc., San Francisco, CA, USA), were
implanted in the first 10 human patients by anterior lamellar
keratoplasty. At 4 years post operation, the stromal implants
remained stably integrated.6 The use of recombinant human
collagen avoids the risk of potential immune response7,8 or
disease transmission9 associated with the transplantation of
animal-source collagen. It was shown that by mimicking the
extracellular matrix of the cornea, the biosynthetic implants
promoted host tissue regeneration and repopulation by host
epithelial cells, nerves, and keratocytes.6,10,11 However,
there has not been any detailed analysis of the shape of
the implanted corneas. Tracking of corneal shape is
important as it determines most of the eye’s refractive
power and hence, visual acuity.12
The goal of this study was to characterize the three-
dimensional (3D) shape of the first human corneas implanted
with biosynthetic stromal substitutes (BSS). The complemen-
tary methodologies used to achieve this goal included (1) the
review of all individual topographies obtained before and after
surgery for these 10 patients; (2) the creation of average
topography maps to identify common shape patterns among
the 10 implanted corneas; and (3) the construction of average
difference maps to compare the implanted corneas at different
time points. The three-dimensional shape of the implanted
corneas was compared to that of normal corneas and (4) the
analysis of standard shape parameters extracted from the
individual topographies and giving a more traditional descrip-
tion of the 3D corneal shape. Finally, comparative data from the
literature describing currently accepted corneal transplanta-
tion methods were analyzed.
METHODS
Patients
The research protocol adhered to the tenets of the Declaration
of Helsinki and it was approved by the Swedish Medical
Products Agency and the Regional Ethical Review Board in
Linko¨ping, Sweden (application no. M205-06), trial registration
(EudraCT no. 2006-006585-42). All patients signed an informed
consent after the nature and potential risks of the procedure
were explained. Eight male and two female patients, aged 18 to
75 years, were grafted with corneal implants. In nine cases,
surgery was warranted by advanced keratoconus and in one
case by corneal scarring impinging on the visual axis. A mean
(6 SD) follow-up of 3.52 6 1.03 years was available at the time
of this study. Only 3-year follow-up topographies were available
for patients 1 and 9, and a 1-year topography for patient 4. For
each patient, a control topography from a healthy subject was
used. These controls were matched for age and sex and had a
spherical equivalent within 6 3.00 D from emmetropia and a
refractive cylinder of less than 1.00 D.
Surgery
All surgeries consisted of anterior lamellar keratoplasties
performed by one of us (P.F.) between October and November
2007 at the Linko¨ping University Hospital, Sweden. Only one
eye per patient underwent surgery. The anterior diseased
portion of the cornea was manually removed to a depth of 400
lm and on a diameter ranging from 6.0 to 6.5 mm, leaving only
a thin layer of posterior stroma, DM, and endothelium. The 500
lm-thick, highly transparent corneal implant was trephined
using a circular punch 0.25 mm larger in diameter than the
recipient bed. It was then anchored into the recipient bed with
three to four overlying 10-0 nylon mattress sutures, as shown in
Figure 1. All sutures were removed during the same visit, on
average 6.5 6 3 weeks after surgery.
Average Map Construction
All topography maps reported in this paper consisted of
corneal elevation maps. Elevation maps were favored over
curvature maps because they provide more comprehensive
shape information, subsequently allowing for any type of
derived analysis, including calculation of curvatures. An
average map has the same appearance as an individual map,
the only difference being that each color point on the
average map represents the average at this specific point of
all the individual measurements for the studied population.
The average map construction methodology used in this
study has been described elsewhere.13 Essentially, average
anterior surface elevation maps were built from individual
anterior surface topographies obtained with the Orbscan II
system (Orbscan, Bausch & Lomb, Rochester, NY, USA) and
saved into numerical tables of 101 by 101 points uniformly
spaced and centered on the visual axis. Left eye topogra-
phies were horizontally flipped to convert them into right
eyes (enantiomorphism).14 Prior to averaging, spatial align-
ment of individual corneas was performed. Each individual
topography Best-Fit Sphere (BFS) was aligned with a
reference BFS, herein defined as the mean BFS of all healthy
controls. The Best-Fit Sphere represents the sphere that best
adjusts to the corneal surface with least-squares regression.
In order to facilitate interpretation, the color scale used for
the average elevation maps was the same as that commonly
used in the commercial topography system for individual
topographies (5-lm color steps, green representing a point
on the BFS).
Difference Maps
A first difference map was used to compare the corneas before
and after surgery. It was computed so that each color point
represented the average of all paired differences at this specific
point. A P value map complemented the difference map,
highlighting in red areas of significant difference (P < 0.05)
and in green, areas of insignificant difference (P ‡ 0.05).13,15 In
order to assess shape stability of the corneas implanted with
the BSS, herein called the BSS corneas, a second difference
map was similarly generated comparing the earliest follow-up
data (within the 1- to 2-year postoperative interval) to the latest
follow-up data (within the 3- to 4-year postoperative interval).
Exact time points of postoperative topographies used to
calculate this difference map are listed in Supplementary
Figure S1 and no replicate measurements were used for any of
the average or difference maps. A third difference map was
generated to compare the preoperative diseased corneas with
the healthy controls (n ¼ 10). And finally, a fourth difference
map was generated to compare the 10 corneas implanted with
the BSS at the time of their last visit to the healthy controls.
These last two difference maps were expressed by computing
a point-by-point difference between the two groups’ average
maps.
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Standard Corneal Shape Parameters
Several topography parameters commonly used to characterize
the corneal shape were also studied, including asphericity,
apical radius of curvature, corneal power, astigmatism, and
surface irregularity. The corneal asphericity coefficient (Q)
indicates the rate at which the corneal curvature changes from
the center to the periphery. In a perfect sphere, Q ¼ 0. A Q
value < 0 indicates that the corneal surface curvature gradually
flattens from center to periphery (prolate shape). A Q value >
0 indicates that the corneal curvature gradually steepens from
center to periphery (oblate). The apical radius of curvature (R)
characterizes the circle tangent to the apex (point of greatest
curvature). The smaller the R value, the greater the curvature
is, and vice versa. The mean corneal power (Mean Pwr) and
astigmatism (Astig Pwr) were measured in the central 0- to 3-
mm radius zone and in the 3- to 5-mm annular peripheral zone.
Astigmatism (Astig) in the 1.5-mm radius central zone was
reported as the difference between the Maximum (Max K) and
Minimum (Min K) keratometry values, respectively, describing
curvature in the steepest and flattest axes. Orientation of the
astigmatism was classified as with-the-rule (steep axis within 6
22.58 from vertical), against-the-rule (steep axis within 6 22.58
from horizontal), or oblique (steep axis within 6 22.58 from
either the 458 or 1358 oblique axes). Surface irregularity was
assessed using the Surface irregularity index given by the
Orbscan system.
Statistical Analyses
Mean values and standard deviations are reported. Student’s t-
tests were used to test for differences in means between
groups and for the point-by-point comparisons of the
topography maps, with adjustment of P values according to
Benjamini’s correction for multiple comparisons.16 Two-tailed
paired Student’s t-tests were used to compare pre- and
postoperative values within the BSS group and two-tailed
unpaired Student’s t-tests were used to compare the BSS
corneas to the healthy controls. The Pearson product-moment
correlation coefficient was calculated to assess correlations
between parameters. The Fisher exact test was used to test for
homogeneity. A P value of less than 0.05 was considered to be
statistically significant. All statistical tests were two-sided. The
analyses were conducted using SAS 9.2 (SAS Institute, Inc.,
Cary, NC, USA) for the shape parameters and Matlab R2011A
(Mathworks, Natick, MA, USA) for average maps comparisons.
RESULTS
Individual pre- and postoperative topographies are shown in
Figures 2A, 2B, and Supplementary Figure S1. Average
elevation maps and corresponding standard deviation maps
are illustrated in Figure 3A, and difference maps with
corresponding P value maps are illustrated in Figure 3B.
Healthy Corneas
The healthy subjects’ average corneal elevation map shown in
Figure 3A (column 1, top row) displayed the concentric
pattern typical of healthy corneas. The apex, in warm colors
(i.e., above the BFS), was surrounded by cold colors (under the
BFS), themselves surrounded by another ring of increasingly
warmer colors toward the periphery. Variability among healthy
individuals was low (6 1.8–8.1 lm in the 3-mm radius central
area), as shown by the yellow and green standard deviation
map (Fig. 3A, column 1, second row).
Corneal Shape Before BSS Implantation
The individual preoperative topographies were available for all
patients except one (patient #5; Fig. 2A). The nine keratoconus
corneas had the typical shape of keratoconic eyes (#1–#9),
with a pronounced paracentral prominence surrounded by a
ring of relative depression below the BFS.
This pattern is well summarized by the preoperative
average map shown in Figure 3A, column 2. Standard deviation
in the diseased eyes before BSS implantation was much larger
(6 9–48 lm in the 3-mm radius central area) than that seen in
the healthy controls. The diseased corneas before BSS
implantation were statistically significantly different from the
healthy corneas, as shown by the difference map and the
predominantly red P value map (Fig. 3B, column 1).
Corneal Shape After BSS Implantation
Figure 2B shows the postoperative topographies at the time
of the last visit for the 10 BSS corneas. The biosynthetic
stromal substitutes implants appeared to be well integrated
into the host corneas. There were no signs of wound
dehiscence or implant extrusion, as evidenced by the absence
of gaps, steps, or extreme changes in curvature at the level of
the wound.
The biosynthetic stromal substitutes corneas were appre-
ciably more irregular than the healthy controls. Two patterns
predominated. (1) A localized, central, or paracentral
prominence (Fig. 2B) was most notable in patients #3, 4,
and 7. This prominence tended to adopt a hexagonal contour,
which matched the area delineated by the overlying mattress
sutures (Figs. 1A–C). (2) A tendency in flattening of the
superior cornea was also noted, which was most distinct in
patients #3, 4, and 5, but also seen in patients #1, 7, 9, and 10
(Fig. 2B). These observations were well illustrated by the
postoperative average map (Fig. 3A, column 3), showing a
paracentral, hexagonal elevation (in orange) and a superior
FIGURE 1. Hexagonal pattern of the mattress sutures imprinted on the anterior corneal surface of the BSS implant (patient #4). (A) Diagram of the
mattress sutures placement. (B) Slit-lamp photograph of the cornea showing the mattress sutures over the BSS implant. (C) Corneal topography.
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crescent-shaped flattening (in purple-blue). The standard
deviation map confirmed the variability among postoperative
corneas (6 11–66 lm in the 3-mm radius central area).
The overall effect of BSS implantation is summarized by the
mean difference map obtained by subtracting the preoperative
topographies from the postoperative topographies (Fig. 3B,
column 2), and consisted essentially in a flattening of the cone
(central blue area). The amount of flattening varied between
patients and did not reach statistical significance, as shown by
the almost entirely green P value map (Fig. 3B, column 2,
second row).
Comparison of the postoperative BSS corneas to healthy
controls (Fig. 3B, column 3) confirmed the presence of a
hexagonal, paracentral bulging and a flattening of the
superior cornea at the level of the superior lid in the operated
eyes.
Standard Corneal Topography Parameters
Standard corneal topography parameters, including asphericity,
apical radius of curvature, corneal steepness, astigmatism, and
surface irregularity, were also studied before and after surgery
FIGURE 2. Individual topographies of the 10 BSS patients. (A) Preoperative topographies. (B) Postoperative topographies taken at the time of the
last visit.
Biosynthetic Corneal Stromal Substitutes IOVS j May 2016 j Vol. 57 j No. 6 j 2358
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/Journals/IOVS/935270/ on 05/10/2016
(Table 1; Figs. 4A–F). Comparisons between pre- and postoper-
ative values showed a mild flattening and decrease in the
amount of surface irregularity in the 0- to 3-mm central cornea.
These changes, however, did not reach statistical significance
(Table 1). Astigmatism in the 0- to 1.5-mm area also showed a
mild improvement, while it increased in the more peripheral
zones. Surface irregularity increased in the 3- to 5-mm surgical
wound zone.
Comparisons between BSS implanted corneas and the
healthy controls showed the following: No significant differ-
ence in asphericity (Q) was found between the two groups
(Table 1) and the corneal power (Mean Pwr) values of the BSS
corneas overlapped those of the healthy eyes (Fig. 4A). Corneal
power, corneal astigmatism, and their variability, were
statistically significantly higher in the BSS corneas than in
healthy eyes, both in the central and peripheral zones (Table 1;
FIGURE 3. Average topography maps. (A) Average elevation maps. First row: Average elevation maps; Second row: Standard deviation maps.
Column 1: Healthy controls maps (average model of 10 healthy controls matched for age and sex). Column 2: Preoperative maps (average of
preoperative topographies). Column 3: Postoperative maps (average of latest postoperative topographies). (B) Difference maps. First row:
Difference maps; Second row: P value maps. Column 1: Preoperative—Healthy controls difference map (difference between the healthy controls
and the preoperative average maps). Column 2: Latest postoperative—Preoperative difference map (average map of the paired differences between
the preoperative and the latest postoperative topographies). Column 3: Latest postoperative—Healthy controls difference map (difference between
the healthy controls average map and the latest postoperative average map). Column 4: (3- to 4-year postoperative) – (1- to 2-year postoperative)
difference map (average map of the paired differences between the earliest topography taken between the first and second years and the latest
topography taken between the third and fourth years after implantation). Time points for each of the postoperative topographies used to build these
difference maps are detailed in Supplementary Figure S1.
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Figs. 4B–D). Surface irregularity was also significantly higher in
BSS eyes, especially at the level of the surgical wound and
sutures (Fig. 4E). The preferential with-the-rule orientation of
astigmatism, typically preponderant among healthy eyes and
observed herein in healthy controls (steep axis close to vertical
in 64% of cases), was also observed in the BSS eyes (Fig. 4F). In
summary, the BSS corneas were steeper and more irregular
than the healthy controls. Their overall asphericity, however,
was not significantly different from that of healthy eyes.
Visual Acuity, Corneal Shape, and Refraction
Before surgery, the best spectacle corrected visual acuity
(BSCVA) was counting fingers in two patients and the average
BSCVA for the rest was 0.74 logMAR (ranging from 0.5 to 1
logMAR).5 At 4 years post implantation, the average BSCVA for
the 10 patients was 0.88 logMAR (0.4–1.0 logMAR).6 While all
patients who received the biosynthetic implants were contact
lens-intolerant before surgery, most of them tolerated rigid
contact lenses after surgery. When considering contact-lens
corrected scores (BCLVA), the mean visual acuity at 4 years was
0.44 logMAR (0.1–1 logMAR), meaning that it improved from
preoperative values in eight patients (mean gain of 0.56
logMAR units, ranging from 0.3 to 1.7 logMAR) and remained
unchanged in two. Figures 5A through 5C describe the
evolution of visual acuity throughout the study period. Overall,
visual acuity was shown to improve continuously from before
to 1 to 2 years after BSS implantation (P¼ 0.0054) and from 1
to 2 years to 3 to 4 years after BSS implantation (P ¼ 0.0126).
While no correlations were found between the BSCVA in
logMAR and spherical equivalent refraction (Fig. 5D) or
refractive cylinder (Fig. 5E), statistically significant positive
correlations were found between the BSCVA in logMAR and
corneal power (Fig. 5F) and surface irregularity (Fig. 5G). A
significant negative correlation was also found between the
BSCVA and the apical radius of curvature (Fig. 5H). In other
words, visual acuity was better when the implanted corneas
were less steep, less irregular, and closer to the shape of the
healthy controls (Figs. 5F–I). In addition, the keratometric
parameters (power and surface irregularity) were better
indicators of spectacle corrected visual acuity than the
strength of the spectacle (amount of refractive spherical
equivalent and cylinder; Figs. 5D–I).
Stability of BSS Implanted Corneas Over Time
In order to assess the overall stability in time of the BSS
corneas, a map was produced consisting of the mean
difference in 3D shape observed between the earliest (within
the 1- to 2-years postoperative interval) and the latest (within
the 3- to 4-years interval) follow-up visits (Fig. 3B, column 4).
Time points of the postoperative topographies used to
calculate this difference map are detailed in Supplementary
Figure S1. The mild postoperative flattening of the central
protrusion seen over time was not statistically significant (P-
value map entirely green).
DISCUSSION
The clinical concept of implanting a corneal substitute instead
of an ex vivo native cornea is new and represents the endpoint
to many years of development.6,10,11,17 As reported recently,
these recombinant human collagen anterior stromal implants
promote rapid re-epithelialization, as well as colonization by
the recipient’s keratocytes and nerves, allowing for the
rehabilitation of corneal function.5,6 Results of this safety
study showed that these implants were stably integrated into
the host corneas, without signs of wound dehiscence or
implant extrusion. Because of the small sample size of this
phase I safety study and because of the variation observed
among the individuals, several analyses were underpowered
and did not reach statistical significance. Trends in data,
however, were observed: the surgery induced a mild flattening
of the corneas. The analyses also revealed postoperative
irregular astigmatism, the presence of a hexagonal, central
prominence delineated by the overlying mattress suture
pattern, and a flattening of the superior cornea under the
superior lid. Average maps were more informative about shape
distribution across the corneal surface than were corneal shape
parameters, which only focused on specific aspects of the
shape and were more likely affected by focal irregularities.
TABLE 1. Comparison of BSS and Normal Subjects
BSS Preoperative, Mean 6 SD BSS Postoperative, Mean 6 SD Controls, Mean 6 SD
Number of subjects 10 10 10
Age 43.0 6 19.1 46.7 6 19.0 47.6 6 18.2
Shape parameters
R 6.99 6 0.87* 6.84 6 1.01† 7.74 6 0.14
Q 0.20 6 0.62 0.26 6 0.56 0.13 6 0.20
0- to 1.5-mm central zone
Max K (KD) 54.49 6 8.71* 52.08 6 6.52† 43.75 6 0.96
Min K (KD) 47.84 6 7.13 46.03 6 7.32 43.04 6 0.82
Astig (KD) 6.64 6 2.89* 6.05 6 2.49† 0.71 6 0.43
0- to 3-mm central zone
Surface irregularity (KD) 8.85 6 3.11* 8.81 6 3.45† 1.25 6 0.55
Mean Pwr (KD) 49.43 6 6.06* 49.23 6 5.75† 43.45 6 0.73
Astig Pwr (KD) 3.82 6 2.17* 5.46 6 5.48† 0.98 6 0.78
3- to 5-mm peripheral zone
Surface irregularity (KD) 10.24 6 3.79* 11.71 6 5.19† 1.61 6 0.46
Mean Pwr (KD) 46.91 6 4.34* 47.49 6 4.84† 43.06 6 0.81
Astig Pwr (KD) 2.35 6 1.29* 3.65 6 2.32† 0.63 6 0.27
* The comparison of the BSS corneas before surgery and the normal controls was statistically significant (Student’s unpaired t-test; P < 0.05).
† The comparison between the BSS-implanted corneas and the normal controls was statistically significant (Student’s unpaired t-test; P < 0.05).
The differences between BSS corneas before and after surgery did not reach statistical significance.
Biosynthetic Corneal Stromal Substitutes IOVS j May 2016 j Vol. 57 j No. 6 j 2360
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/Journals/IOVS/935270/ on 05/10/2016
Comparison of BSS Implantation With Traditional
Corneal Transplantation
Until recently, the only widely accepted surgical options for
the replacement of corneas with end-stage keratoconus or
anterior stromal scars were PK and DALK, using eye bank
donor corneas. Table 2 compares the corneal shape parameter
values reported in the literature after PK or DALK with those
reported herein after BSS implantation. Neither PK, DALK, nor
BSS have been reported to yield corneal topography values
similar to those observed in normal nonoperated eyes.
Comparison With Penetrating Keratoplasty
Penetrating keratoplasty, which consists in the replacement of
the full thickness of the cornea, remains the gold standard for
corneal transplantation. Despite generally good postoperative
corrected visual acuity,18–22 PK often leaves significant
ametropia and severe astigmatism, and most importantly, these
results are unpredictable. Mean astigmatism values of 3.4 to 4.9
D, ranging from 0.5 to 8.98 D are typically reported after
PK.18,20,23,24 Our results show that the BSS corneas were
steeper (49.23 6 5.75 D) than usually described after PK
(43.00–45.9; Table 2).18,22,24 Corneal astigmatism in BSS eyes
was also higher than routinely reported after PK, with a mean
value of 6.05. Surface irregularity of BSS corneas was
approximately double that reported in post-PK patients.20
Comparison With Deep Anterior Lamellar
Keratoplasty
In deep anterior lamellar keratoplasty, the full thickness of the
diseased stroma is replaced, preserving only the host’s 20-lm
FIGURE 4. Distribution of the corneal shape parameters for BSS implanted and healthy control eyes. (A) Mean power as a function of corneal zone.
(B) Mean power standard deviation as a function of corneal zone. (C) Astigmatism as a function of corneal zone. (D) Astigmatism standard deviation
as a function of corneal zone. (E) Surface irregularity as a function of corneal zone. (F) Orientation of corneal astigmatism.
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thick endothelial and Descemet’s layers.23 As far as the global
3D corneal shape is concerned, the outcome after DALK is
thus very similar to that after PK, with residual steepness, a
large range of astigmatism, and surface irregularity.25 Our
results showed that central corneal steepness after BSS
implantation was more than that reported for DALK (44.4–
47.2 D), DALK and PK both inducing more flattening than BSS
in keratoconus eyes.22,26–28 However, peripheral corneal
steepness in BSS eyes was comparable to that found in the
literature for DALK (47.84 6 5.37 D; Table 2).24 The mean
astigmatism value for the BSS corneas was higher than those
for DALK (2.25–5.41 D)20,23,24,26–29 and surface irregularity
was approximately double that reported post-DALK.20
Ten of the 12 articles cited in Table 2 included only
keratoconus patients, one mainly involved keratoconus pa-
tients and in the other, keratoconus patients showed results
similar to those of their entire study group, thus allowing us to
compare these historical results to those of the BSS patients. In
addition, complete suture removal had been performed by the
time final measurements were taken in all studies cited, as it
was the case for the BSS implants. One notable point is that the
BSS corneas tolerated a relatively short suture removal time of
6.5 6 3 weeks after surgery. Sutures are rarely removed until 1
year after PK and between 5 and 27 months after DALK.26 As
sutures can lead to several complications, including infection,
vascularization, and rejection, and knowing that late suture
removal delays visual rehabilitation, earlier removal, when
possible, represents an advantage.
Visual Acuity and Corneal Shape
Visual acuity improved continuously throughout the study
period (P < 0.05). Visual acuity was shown to be closely linked
to corneal shape and surface irregularity. The increased corneal
steepness, the irregular astigmatism due to the overlying
mattress sutures, and the corneal flattening under the superior
lid have all, to some extent, affected visual acuity in the BSS
implanted eyes. The small size of the implants (6.25–6.75 mm
diameter) also induced irregular astigmatism, as confirmed by
the mean surface irregularity index in the 3- to 5-mm wound
zone. Larger graft diameters ranging from 7.50 to 8.75 mm are
generally used for DALK and PK, to minimize surface distortion
due to the wound and sutures30,31 and postoperative myopia.32
This is especially important for keratoconus eyes, for which
corneal ectasia often extends far into the residual host
peripheral cornea.25,31 It should be noted that the stromal
haze described previously at the stromal-implant interface5
most probably also affected visual acuities.23 A deep anterior
lamellar keratoplasty surgical technique using larger graft
diameter implants will be considered for future clinical trials.
Traditional Limits of Corneal Replacement Using
Human Native Tissue
At the present time, only DMEK allows restitution of an almost
perfectly normal corneal shape after corneal lamellar trans-
plantation, with practically optimal visual rehabilitation.33,34
All transplantation techniques involving a corneal surface
wound and sutures to hold the graft (whether the graft is
anterior lamellar, deep anterior lamellar, or full thickness)
potentially induce significant astigmatism, ametropia (usually
on the myopic side), and surface irregularity, with a large
variability in the results (Table 2).35–40 Postoperative corneal
shape is influenced by the inevitable disparities in curvature
and thickness between the donor and recipient corneas, as
well as by the architecture of the donor and recipient cuts.
Various attempts have been made to optimize corneal shape-
related outcomes following PK or DALK. Mechanical and
femtosecond laser assisted trephination techniques have been
refined to ensure better apposition between donor and host
corneas,21,41–44 and great attention has been paid to the
recipient bed and graft diameters,31,45 as well as to suturing
techniques.29,46,47 A number of refractive surgery procedures
FIGURE 5. Visual acuity progression and correlation with shape
parameters. (A) Evolution of best corrected visual acuity (BCVA) over
time. (B) Evolution of BCVA from before to 1 to 2 years after BSS
implantation. (C) Evolution of BCVA from 1 to 2 years to 3 to 4 years
after BSS implantation. Correlations between BSCVA and (D) spherical
equivalent refraction, (E) refractive cylinder, (F) mean power, (G)
surface irregularity in the central 0- to 3-mm radius zone, (H) apical
radius of curvature (R), and (I) asphericity (Q) for eyes implanted with
a BSS at the time of the latest postoperative visit. Visual acuity is
reported in logMAR units (0 logMAR¼ 20/20 and 1 logMAR¼ 20/200).
Zones in grey represent the range of values measured in healthy
controls. Empty circles represent the patient with corneal scar.
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have also been developed to improve corneal shape in
postkeratoplasty eyes, including relaxing incisions, intracor-
neal ring segments, and topography guided photoablative
surgery. Despite major efforts, however, surface irregularity
and instability remain a challenge with traditional PK or DALK
techniques.
Potential of Biosynthetic Corneal Implants
Based on the analysis reported herein and based on the
literature, BSS implantation, which is still at its earliest stages,
faces the same limitations as traditional transplantation
techniques in terms of 3D corneal shape, namely astigmatism,
steepness, and surface irregularity. Although BSS have not
proven to be superior with regards to 3D shape outcomes, the
adjustments needed to exceed the standard methods of
transplantation are theoretically accessible. Given that astig-
matism, steepness, and surface irregularity are outcomes
related to the biomechanical properties of the implant’s
material and that the latter can be optimized during
production, biomaterials technology may offer an entirely
new window of opportunity. The rigid poly (methyl methac-
rylate) (PMMA) used to produce KPros represents an example
of stable surface shape control in the context of corneal
replacement. Poly (methyl methacrylate), however, contrary to
recombinant human collagen biomaterials, is an inert material,
incompatible with colonization by host’s cells and corneal
tissue regeneration. Further studies are needed to confirm that
increasing the BSS biomaterial’s rigidity will allow sutures to be
placed more peripherally, with less suture imprinting, resulting
in smoother re-epithelialization. Future studies will also
indicate if more rigid biosynthetic material can better mask
the central keratoconic protrusion and better resist compres-
sion by the upper eyelid. In this context, comparing the 3D
shape of BSS implanted corneas with that of healthy corneas
becomes particularly interesting, as it allows to better
understand and guide the future development of biosynthetic
implants.
In conclusion, previous studies have shown that the
recombinant human collagen stromal implants offer significant
advantages over native transplants, including sterility and
absence of immune rejection. They represent a potentially
safe alternative to donor organ transplantation for anterior
stromal disease, with active colonization by the recipient’s
epithelial cells, keratocytes, and nerves. The present study
focused on the 3D corneal shape of the first 10 human patients
implanted with a BSS. It showed that these implants remained
stably integrated into the host corneas over the 4-year follow-
up period, without signs of wound dehiscence or implant
extrusion. The biosynthetic stromal substitutes corneas
showed steeper surface curvatures and were more irregular
than the healthy controls. Future studies will show if
optimization of implant biomaterial properties will help
minimize postoperative astigmatism and ametropia, an oppor-
tunity that is not available for traditional corneal transplanta-
tion techniques using human donor tissue.
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